This trial is testing a new way to help lung cancer patients quit smoking, by framed messaging and nicotine replacement therapy. If successful, this study could help many people quit smoking.
0 Primary · 1 Secondary · Reporting Duration: 6 month follow-up
367 Total Participants · 6 Treatment Groups
Primary Treatment: Gain-framed messaging plus NRT · No Placebo Group · Phase 2
Age 18+ · All Participants · 5 Total Inclusion CriteriaMark “Yes” if the following statements are true for you: